DETAILED NOTES ON COPYRIGHT DERIVATIVES

Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs targeted at expanding the horizons of cytokine-based immunotherapy, specifically for cancers where remedy options remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy can